I am the the Founder of JY Scientific Consulting LLC, and the Chief Strategy Officer, Quantitative Biosciences Institute, University of California San Francisco. Previously, I was the Therapeutic Area Head of Infectious Diseases and Global Head of Pandemic Preparedness, at Roche Pharma Research and Early Development (pRED) in Basel, Switzerland. I served as a Board Member on the AMR Action Fund and on the Intrepid Alliance for Pandemic Prevention, Preparedness and Response, and was also a member of the Leadership Team of the FNIH/NIH-led ACTIV public-private partnership on COVID-19. Prior to Roche, I was a Professor at the Salk Institute for Biological Studies in La Jolla, California. I am a Fellow of the American Academy of Microbiology. I have received the American Society for Microbiology’s Eli Lilly and Company-ELANCO Research Award, the NIH Office of the Director’s Award, and the Charles A. Sanders M.D. Partnership Award from the Foundation for the NIH.